• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 114-128 of 232 results

1013 Exhibit: Fosamax Drug Label

Document PGR2018-00001, No. 1013-10 Exhibit - Fosamax Drug Label (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1037 Exhibit: Annex 2 WHO good mfg practices for pharm prods main principles

Document PGR2018-00001, No. 1037-21 Exhibit - Annex 2 WHO good mfg practices for pharm prods main principles (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1047 Exhibit: Bisphosphonates Potential therapeutic agents for disease modificatio...

Document PGR2018-00001, No. 1047-29 Exhibit - Bisphosphonates Potential therapeutic agents for disease modification in osteoarthritis (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1002 Exhibit: File History of US Patent No 9,539,268

Document PGR2018-00001, No. 1002-2 Exhibit - File History of US Patent No 9,539,268 (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1030 Exhibit: Eliminating the need for fasting with oral administration of bisphospho...

Document PGR2018-00001, No. 1030-17 Exhibit - Eliminating the need for fasting with oral administration of bisphosphonates (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1055 Exhibit: Prospective examination of pain related and psychological predictors...

Document PGR2018-00001, No. 1055-36 Exhibit - Prospective examination of pain related and psychological predictors of CRPS like phenomena following total knee arthroplasty a preliminary study (P.T.A...

cite Cite Document

1009 Exhibit: Leonard

Document PGR2018-00001, No. 1009-8 Exhibit - Leonard (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1003 Exhibit: Declaration of Stephen Bruehl, PhD

Document PGR2018-00001, No. 1003-3 Exhibit - Declaration of Stephen Bruehl, PhD (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1081 Exhibit: Zoledronic acid does not reduce MRI erosive progression in PsA but m...

Document PGR2018-00001, No. 1081-56 Exhibit - Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema the Zoledronic Acid in Psoriatic Arthritis Study (P.T.A.B....

cite Cite Document

1048 Exhibit: Effect of risedronate on joint structure and symptoms of knee osteoar...

Document PGR2018-00001, No. 1048-30 Exhibit - Effect of risedronate on joint structure and symptoms of knee osteoarthritis results of the BRISK randomized, controlled trial (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1083 Exhibit: Characterisation of a Freunds complete adjuvant induced model of ch...

Document PGR2018-00001, No. 1083-58 Exhibit - Characterisation of a Freunds complete adjuvant induced model of chronic arthritis in mice (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1056 Exhibit: Development of a severity score for CRPS

Document PGR2018-00001, No. 1056-37 Exhibit - Development of a severity score for CRPS (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1027 Exhibit: Intl Patent App Pub No WO2011014781

Document PGR2018-00001, No. 1027-14 Exhibit - Intl Patent App Pub No WO2011014781 (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1063 Exhibit: Chapter 3 Pharmacokinetics in Modern Pharm

Document PGR2018-00001, No. 1063-40 Exhibit - Chapter 3 Pharmacokinetics in Modern Pharm (P.T.A.B. Oct. 10, 2017)

cite Cite Document

1033 Exhibit: MER 101 tablets A pilot bioavailability study of a novel oral formulatio...

Document PGR2018-00001, No. 1033-18 Exhibit - MER 101 tablets A pilot bioavailability study of a novel oral formulation of zoledronic acid (P.T.A.B. Oct. 10, 2017)

cite Cite Document
<< 1 2 3 4 5 ... 8 9 10 11 12 ... 14 15 16 >>